A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

In Utah, patients who consent to "hormonal transgender treatment" or surgery on "sex characteristics" while they are minors ...

Tuberculosis remains one of the deadliest infectious diseases worldwide, with drug-resistant strains posing a significant ...

How do highly successful people handle some of life’s biggest obstacles? Twenty years of research points to a simple brain ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...

Shoulder symptoms led to an average of 9.6 million physician visits in 2015 and 2016 in the United States. The most common ...

Subcutaneous injection of abelacimab results in lower levels of free factor XI and significantly fewer bleeding events than rivaroxaban in patients with atrial fibrillation at moderate-to-high risk ...

Study finds three new safe and effective drug regimens to fight multidrug-resistant TB. The treatments, which include recently discovered TB drugs, give new options for shorter, personalized treatment ...

Scientists have discovered three powerful new drug regimens that offer more effective treatment for tuberculosis—bringing ...

The most common cardiovascular killer in maternal medicine is also among the most misdiagnosed. Peripartum cardiomyopathy ...